Skip to search formSkip to main contentSkip to account menu

ganglioside, GD2

Known as: GD2 ganglioside, GalNAc(beta 1->4)-[NeuAc(alpha 2->8)NeuAc(alpha 2->3)]Gal(beta 1->4)GlcCer, Ganglioside GD2 
A cell surface antigen expressed on all tumors of neuroectodermal origin, including melanoma, neuroblastomas, sarcoma, astrocytomas, and small cell… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Abstract The expression of ganglioside GD2 on the cell lines of colorectal adenocarcinoma HT29 and CaCo-2, as well as on the… 
2017
2017
Breast cancer stem cells (BCSCs) have been characterized as a fraction of cells in primary tumors that are drug resistant and… 
2016
2016
Methodological approaches to the creation of nanoparticles based on chitosan derivatives and targeted to the GD2-positive tumor… 
2015
2015
Mechanisms leading to inhibitory effects of an anti-GD2 ganglioside (GD2) 14G2a mouse monoclonal antibody (mAb) and PI3K/Akt/mTOR… 
2012
2012
A major goal of tumor immunotherapy is the induction of long-lasting systemic T-cell immunity. Bispecific antibodies (bsAbs) that… 
2007
2007
FIELD: medicine. SUBSTANCE: what is offered is the use of monoclonal antibodies recognising the O-acetylated form of ganglioside… 
Review
2007
Review
2007
Purpose:We previously generated a mouse monoclonal antibody (mAb) specific for the tumorassociated GD2 ganglioside antigen. Here… 
1981
1981
The rabbit antibody response to the human blood group P glycolipid antigen, globoside, GalNAc(beta 1-3)Gal(alpha 1-4)Gal(beta 1-4…